期刊
CANCER LETTERS
卷 273, 期 2, 页码 225-232出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2008.08.012
关键词
Cyclooxygenase; Prostaglandin; Colon cancer; Epidermal growth factor receptor; Azoxymethane
类别
资金
- Huntsman Cancer Foundation
- R. Harold Burton Foundation
- National institutes of Health [R01-CA95463, P01-CA73992]
- Cancer Center Support [P30 CA042014-20]
- Pre-doctoral Fulbright Award
We generated mice expressing a COX-2 transgene in colon epithelium and found that they did not develop spontaneous colon tumors. But when treated with azoxymethane, a colon carcinogen, COX-2 mice had a higher tumor load compared to wild-type mice. There was no change in the number of pre-neoplastic lesions, indicating that COX-2 does not affect tumor initiation. Tumors in the COX-2 transgenic mice had higher levels of phosphorylated epidermal growth factor receptor and Akt compared to wild-type mice. Collectively, our data indicate that COX-2 promotes colon tumor progression, but not initiation, and it does so, in part, by activating EGFR and Akt signaling pathways. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据